基于CEST机制的pH成像方法、原理和应用

doi:10.11938/cjmr20182664

摘要/Abstract

摘要： 化学交换饱和转移（Chemical Exchange Saturation Transfer，CEST）技术作为一种新型的磁共振成像（Magnetic Resonance Imaging，MRI）技术.它的原理为溶质池中被激发饱和的质子与游离水中未被饱和的质子间的化学交换，能够引起水质子磁共振信号的下降，从而获得组织内生物分子的相关信息.由于质子间的交换速率k_ex与组织微环境的pH值之间存在直接联系，因而可以通过溶质质子的CEST信号对活体组织进行pH成像.目前用于pH成像的溶质分子既包括内源性游离的蛋白质、多肽分子，还包括一系列的外源性小分子和金属螯合物.通过不同类型的比率法、内源性胺和酰胺浓度-独立检测（Amine and Amide Concentration-independent Detection，AACID）等成像方法，能够获得肾脏、中风脑组织以及肿瘤组织的pH图谱.本文详细总结了2000年以来利用CEST技术进行pH成像方面的研究进展，包括对比剂、成像方法和相关应用，展望了活体组织pH成像的发展趋势和应用前景.

关键词: 磁共振成像(MRI), 化学交换饱和转移(CEST), pH成像, 比率法, 对比剂

Abstract: Chemical exchange saturation transfer (CEST) is a novel molecular magnetic resonance imaging (MRI) method that makes full use of the chemical exchange between water protons and exchangeable protons from solute molecules. Through chemical exchanges, the MRI signal of bulk water decreases when saturating at specific frequency of solute protons. Important biological information related to the chemical exchange processes could be extracted from the amplitude of water signal decrease. For example, the CEST signals have been used for in vivo pH imaging since the proton exchange rate is often pH-dependent. CEST signals originated from endogenous proteins/peptides and exogenous small molecule/metal chelate probes have been used for in vivo pH imaging. Using the ratiometric methods or the amine and amide concentration-independent detection (AACID) methods, in vivo pH maps have been acquired from kidneys, ischemic brain and tumors. In this paper, we thoroughly reviewed the progresses during the past twenty years in the field of in vivo pH imaging with CEST contrast. Principles, methods and applications were discussed, as well as development trends and future directions.

Key words: magnetic resonance imaging (MRI), chemical exchange saturation transfer (CEST), pH imaging, ratiometric procedure, contrast agents

中图分类号:

O482.53

陶泉, 易佩伟, 魏国境, 冯衍秋. 基于CEST机制的pH成像方法、原理和应用[J]. 波谱学杂志, 2018, 35(4): 505-519.

TAO Quan, YI Pei-wei, WEI Guo-jing, FENG Yan-qiu. pH Imaging Based on Chemical Exchange Saturation Transfer: Principles, Methods, Applications and Recent Progresses[J]. Chinese Journal of Magnetic Resonance, 2018, 35(4): 505-519.

参考文献

[1] ASHBY B S. pH studies in human malignant tumours[J]. The Lancet, 1966, 288(7458):312-315.
[2] LI C, XIA J S, WEI X B, et al. pH-activated near-infrared fluorescence nanoprobe imaging tumors by sensing the acidic microenvironment[J]. Adv Funct Mater, 2010, 20(14):2222-2230.
[3] VĀVERE A L, BIDDLECOMBE G B, SPEES W M, et al. A novel technology for the imaging of acidic prostate tumors by positron emission tomography[J]. Cancer Res, 2009, 69(10):4510-4516.
[4] WIKE-HOOLEY J L, VAN DEN BERG A P, VAN DER ZEE J, et al. Human tumour pH and its variation[J]. Eur J Cancer Clin Oncol, 1985, 21(7):785-791.
[5] YOO B, PAGEL M D. An overview of responsive MRI contrast agents for molecular imaging[J]. Front Biosci, 2008, 13:1733-1752.
[6] LIU G S, SONG X L, CHAN K W Y, et al. Nuts and bolts of chemical exchange saturation transfer MRI[J]. NMR Biomed, 2013, 26(7):810-828.
[7] VAN ZIJL P C, YADAV N N. Chemical exchange saturation transfer (CEST):what is in a name and what isn't?[J]. Magn Reson Med, 2011, 65(4):927-948.
[8] YANG Y G, CHEN Z, CAI C B, et al. Factors affecting chemical exchange saturation transfer imaging on 1.5 T Clinical MRI scanners[J]. Chinese J Magn Reson, 2017, 34(3):275-282. 杨永贵, 陈忠, 蔡聪波, 等. 1.5 T磁共振化学交换饱和转移成像的影响因素分析[J]. 波谱学杂志, 2017, 34(3):275-282.
[9] CHEN L Q, PAGEL M D. Evaluating pH in the extracellular tumor microenvironment using CEST MRI and other imaging methods[J]. Adv Radiol, 2015:206405.
[10] HANCU I, DIXON W T, WOODS M, et al. CEST and PARACEST MR contrast agents[J]. Acta Radiol, 2010, 51(8):910-923.
[11] LINDEMAN L R, RANDTKE E A, HIGH R A, et al. A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH[J]. Magn Reson Med, 2018, 79(5):2766-2772.
[12] WARD K M, ALETRAS A H, BALABAN R S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)[J]. J Magn Reson, 2000, 143(1):79-87.
[13] GRAD J, BRYANT R G. Nuclear magnetic cross-relaxation spectroscopy[J]. J Magn Reson, 1990, 90(1):1-8.
[14] HINGORANI D V, BERNSTEIN A S, PAGEL M D. A review of responsive MRI contrast agents:2005-2014[J]. Contrast Media Mol Imaging, 2015, 10(4):245-265.
[15] WARD K M, ALETRAS A H, BALABAN R S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)[J]. J Magn Reson, 2000, 143(1):79-87.
[16] AIME S, CALABI L, BIONDI L, et al. Iopamidol:Exploring the potential use of a well-established x-ray contrast agent for MRI[J]. Magn Reson Med, 2005, 53(4):830-834.
[17] LONGO D L, DASTRÙ W, DIGILIO G, et al. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys:In vivo studies in mice at 7 T[J]. Magn Resona Med, 2011, 65(1):202-211.
[18] CHEN M M, CHEN C Y, SHEN Z W, et al. Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI[J]. Oncotarget, 2017, 8(28):45759.
[19] CHEN L Q, HOWISON C M, JEFFERY J J, et al. Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI[J]. Magn Reson Med, 2014, 72(5):1408-1417.
[20] LONGO D L, SUN P Z, CONSOLINO L, et al. A general MRI-CEST ratiometric approach for pH imaging:demonstration of in vivo pH mapping with iobitridol[J]. J Am Chem Soc, 2014, 136(41):14333-14336.
[21] MCMAHON M T, GILAD A A, ZHOU J Y, et al. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP):pH calibration for poly-L-lysine and a starburst dendrimer[J]. Magn Reson Med, 2006, 55(4):836-847.
[22] YANG X, SONG X L, RAY BANERJEE S, et al. Developing imidazoles as CEST MRI pH sensors[J]. Contrast Media Mol Imaging, 2016, 11(4):304-312.
[23] MELKUS G, GRABAU M, KARAMPINOS D C, et al. Ex vivo porcine model to measure pH dependence of gagCEST in the inter-vertebral disc[J]. Magn Resona Med, 2014, 71(5):1743.
[24] ZHANG S R, ZHOU K J, HUANG G, et al. A novel class of polymeric pH-responsive MRI CEST agents[J]. Chem Commun, 2013, 49(57):6418-6420.
[25] AIME S, BARGE A, DELLI CASTELLI D, et al. Paramagnetic lanthanide (Ⅲ) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications[J]. Magn Reson Med, 2002, 47(4):639-648.
[26] SHETH V R, LIU G S, LI Y G, et al. Improved pH measurements with a single PARACEST MRI contrast agent[J]. Contrast Media Mol Imaging, 2012, 7(1):26-34.
[27] LIU G S, LI Y G, SHETH V R, et al. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent[J]. Mol Imaging, 2012, 11(1):47-57.
[28] DELLI CASTELLI D, FERRAUTO G, CUTRIN J C, et al. In vivo maps of extracellular pH in murine melanoma by CEST-MRI[J]. Magn Reson Med, 2014, 71(1):326-332.
[29] RANCAN G, DELLI CASTELLI D, AIME S. MRI CEST at 1T with large µeff Ln³⁺ complexes Tm³⁺-HPDO3A:An efficient MRI pH reporter[J]. Magn Reson Med, 2016, 75(1):329-336.
[30] KRCHOVÁ T, GÁLISOVÁ A, JIRÁK D, et al. Ln (Ⅲ)-complexes of a DOTA analogue with an ethylenediamine pendant arm as pH-responsive PARACEST contrast agents[J]. Dalton Trans, 2016, 45(8):3486-3496.
[31] ZHOU J Y, LAL B, WILSON D A, et al. Amide proton transfer (APT) contrast for imaging of brain tumors[J]. Magn Reson Med, 2003, 50(6):1120-1126.
[32] ZHOU J Y, PAYEN J F, WILSON D A, et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI[J]. Nat Med, 2003, 9(8):1085-1090.
[33] SUN P Z, SORENSEN A G. Imaging pH using the chemical exchange saturation transfer (CEST) MRI:correction of concomitant RF irradiation effects to quantify CEST MRI for chemical exchange rate and pH[J]. Magn Reson Med, 2008, 60(2):390-397.
[34] MCVICAR N, LI A X, GONCALVES D F, et al. Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI[J]. J Cereb Blood Flow Metab, 2014, 34(4):690-698.
[35] SUN P Z, ZHOU J Y, SUN W Y, et al. Detection of the ischemic penumbra using pH-weighted MRI[J]. J Cerebral Blood Flow Metab, 2007, 27(6):1129-1136.
[36] WARD K M, BALABAN R S. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST)[J]. Magn Reson Med, 2000, 44(5):799-802.
[37] LONGO D L, BUSATO A, LANZARDO S, et al. Imaging the pH evolution of an acute kidney injury model by means of iopamidol, a MRI-CEST pH-responsive contrast agent[J]. Magn Reson Med, 2013, 70(3):859-864.
[38] CHEN L Q, RANDTKE E A, JONES K M, et al. Evaluations of tumor acidosis within in vivo tumor models using parametric maps generated with acidoCEST MRI[J]. Mol Imaging Biol, 2015, 17(4):488-496.
[39] MOON B F, JONES K M, CHEN L Q, et al. A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH[J]. Contrast media & molecular imaging, 2015, 10(6):446-455.
[40] MÜLLER-LUTZ A, KHALIL N, SCHMITT B, et al. Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner[J]. MAGMA, 2014, 27(6):477-485.
[41] JONES K M, RANDTKE E A, YOSHIMARU E S, et al. Clinical translation of tumor acidosis measurements with AcidoCEST MRI[J]. Mol Imaging Biol, 2017, 19(4):617-625.
[42] WU Y, ZHOU I Y, IGARASHI T, et al. A generalized ratiometric chemical exchange saturation transfer (CEST) MRI approach for mapping renal pH using iopamidol[J]. Magn Reson Med, 2018, 79(3):1553-1558.
[43] ALBATANY M, LI A, MEAKIN S, et al. Dichloroacetate induced intracellular acidification in glioblastoma:in vivo detection using AACID-CEST MRI at 9.4 Tesla[J]. J Neurooncol, 2018, 136(2):255-262.
[44] SUN P Z, WANG E, CHEUNG J S. Imaging acute ischemic tissue acidosis with pH-sensitive endogenous amide proton transfer (APT) MRI-correction of tissue relaxation and concomitant RF irradiation effects toward mapping quantitative cerebral tissue pH[J]. Neuroimage, 2012, 60(1):1-6.
[45] GOERKE S, ZAISS M, BACHERT P. Characterization of creatine guanidinium proton exchange by water-exchange (WEX) spectroscopy for absolute-pH CEST imaging in vitro[J]. NMR Biomed, 2014, 27(5):507-518.
[46] MCMAHON M T, GILAD A A, ZHOU J Y, et al. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP):pH calibration for poly-L-lysine and a starburst dendrimer[J]. Magn Reson Med, 2006, 55(4):836-847.
[47] SUN P Z, WANG Y, DAI Z Z, et al. Quantitative chemical exchange saturation transfer (qCEST) MRI-RF spillover effect-corrected omega plot for simultaneous determination of labile proton fraction ratio and exchange rate[J]. Contrast Media Mol Imaging, 2014, 9(4):268-275.
[48] HENKELMAN R M, STANISZ G J, GRAHAM S J. Magnetization transfer in MRI:a review[J]. NMR Biomed, 2001, 14(2):57-64.
[49] KALTSCHNEE L, KNOLL K, SCHMIDTS V, et al. Extraction of distance restraints from pure shift NOE experiments[J]. J Magn Reson, 2016, 271:99-109.
[50] ZHANG M, LU J H, CAI C B, et al. Effects of lipids signals on nuclear overhauser enhancement contrast imaging at 7 T[J]. Chinese J Magn Reson, 2015, 32(4):606-617. 张苗, 卢建华, 蔡聪波, 等. 7 T下脂肪对基于NOE的磁共振对比成像的影响[J]. 波谱学杂志, 2015, 32(4):606-617.
[51] JONES C K, SCHLOSSER M J, VAN ZIJL P, et al. Amide proton transfer imaging of human brain tumors at 3T[J]. Magn Reson Med, 2006, 56(3):585-592.